文献速递白血病

11q23重排及t(8;16)急性髓系白血病中BRE基因C端过表达由基因内转录起始所致

C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.
PubMed 文献 · Leukemia · 2017-09-05

研究在BRE基因内含子4发现富集活跃染色质标记的启动子,导致此前未知的C端BRE转录本双等位基因强表达;该转录本在超过50%的11q23/KMT2A重排和t(8;16)/KAT6A-CREBBP病例中高表达,而在其他AML亚群和正常组织中几乎缺失。报告基因实验显示KMT2A-MLLT3可反式激活该基因内启动子,表观基因组分析还发现97个额外基因内启动子标记且常被KMT2A结合。

要点

  • BRE内含子4存在活跃染色质标记富集的启动子,驱动C端BRE转录本双等位基因强表达。
  • 该转录本在超过50%的11q23/KMT2A重排和t(8;16)/KAT6A-CREBBP病例中高表达,其他AML亚群和正常组织几乎不表达。
  • KMT2A-MLLT3可反式激活该基因内BRE启动子,并可能参与情境依赖性致癌程序。

核心结论

  • 11q23重排及t(8;16)急性髓系白血病中C端BRE过表达由BRE内含子4的基因内转录起始所致。

研究设计与样本

  • 研究对BRE基因内含子4的启动子及C端BRE转录本进行鉴定,并开展报告基因实验与表观基因组分析。

主要发现

  • BRE内含子4的启动子富集活跃染色质标记,导致此前未知的C端BRE转录本双等位基因强表达,该转录本以内含子4序列剪接至外显子5及下游序列起始。
  • 新BRE转录本在超过50%的11q23/KMT2A重排和t(8;16)/KAT6A-CREBBP病例中高表达,在其他AML亚群和正常组织中几乎缺失。
  • 报告基因实验中白血病特异性融合蛋白KMT2A-MLLT3反式激活基因内BRE启动子。
  • 表观基因组分析发现97个额外基因内启动子标记常被KMT2A结合,对应基因在该AML亚型中较其他组高表达。
  • 一例复发AML中观察到ins(11;2)将CHORDC1融合至BRE,融合位点位于KMT2A重排和KAT6A-CREBBP AML中基因内转录起始区域。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Overexpression of the BRE (brain and reproductive organ-expressed) gene defines a distinct pediatric and adult acute myeloid leukemia (AML) subgroup. Here we identify a promoter enriched for active chromatin marks in BRE intron 4 causing strong biallelic expression of a previously unknown C-terminal BRE transcript. This transcript starts with BRE intron 4 sequences spliced to exon 5 and downstream sequences, and if translated might code for an N terminally truncated BRE protein. Remarkably, the new BRE transcript was highly expressed in over 50% of 11q23/KMT2A (lysine methyl transferase 2A)-rearranged and t(8;16)/KAT6A-CREBBP cases, while it was virtually absent from other AML subsets and normal tissues. In gene reporter assays, the leukemia-specific fusion protein KMT2A-MLLT3 transactivated the intragenic BRE promoter. Further epigenome analyses revealed 97 additional intragenic promoter marks frequently bound by KMT2A in AML with C-terminal BRE expression. The corresponding genes may be part of a context-dependent KMT2A-MLLT3-driven oncogenic program, because they were higher expressed in this AML subtype compared with other groups. C-terminal BRE might be an important contributor to this program because in a case with relapsed AML, we observed an ins(11;2) fusing CHORDC1 to BRE at the region where intragenic transcription starts in KMT2A-rearranged and KAT6A-CREBBP AML.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Marneth AE, Prange KHM, Al Hinai ASA, et al. C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation. Leukemia. 2017. PMID: 28871137. doi:10.1038/leu.2017.280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。